However, this potential cross-reactivity does not conceal specific reactivity against various TGs that may exist since none of the controls or AD patients had significantly elevated IgA-anti-TG1 and/or IgA-anti-TG3 responses in association with IgA-anti-TG2 responses. Here, TGM2 is linked to Alzheimer disease.